Discover how CRISPR-Cas9 technology is revolutionizing lung cancer research by identifying genetic vulnerabilities in EGFR-mutant non-small cell lung cancer cells.
Discover how tyrosine phosphorylation of β-catenin drives drug resistance in EGFR-mutant lung cancer and the promising research behind this molecular mechanism.
Discover how the ZC3H15 protein regulates EGFR stability to promote glioblastoma progression in this groundbreaking cancer research article.
Discover how rolling-translated EGFR variants sustain signaling in glioblastoma through circular RNA mechanisms and their clinical implications.
Discover how DHA from fish oil triggers EGFR degradation in lung cancer cells through dual degradation pathways - a breakthrough in cancer research.
Explore how mutant EGFR proteins interact with Hsp90 chaperones and how Geldanamycin triggers their degradation in cancer treatment.